Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care March 6, 2026
Identifying Therapeutic Alternatives in Medicare Drug Price Negotiation: The Case of Etanercept March 6, 2026
Trust and Regulation: Assuring Scientific Independence in the FDA’s Emergency Use Authorization Process March 6, 2026
Regulatory Review Duration and Differences in Submission Times of Drugs in the United States and Europe, 2011 to 2020 March 6, 2026
Infections Following Bispecific Antibodies in Myeloma: a Systematic Review and Meta-Analysis March 6, 2026
Characteristics of Post Hoc Subgroup Analyses of Oncology Clinical Trials: A Systematic Review March 6, 2026
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022: an Interrupted Time-Series Analysis March 6, 2026